TickerFacts.

McKesson Corp (MCK): EBITDA

Operating income plus depreciation and amortization for the same annual period and currency, computed by TickerFacts from the filed figures. Not the company's adjusted EBITDA; a year without both inputs is left out.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the years ended 2010-03-31, 2012-03-31, 2013-03-31 (for example after a spin-off or a discontinued operation), while the year before each was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

$6.94B
Year ended 2026-03-31
$7.26B
Trailing 12 months to 2026-06-30
+11.6%
3-year compound annual growth
+4.6%
10-year compound annual growth
$8.03B2009-03-31: $1.51B2010-03-31: $2.48B2011-03-31: $2.32B2012-03-31: $2.62B2013-03-31: $2.93B2014-03-31: $3.17B2015-03-31: $3.98B2016-03-31: $4.43B2017-03-31: $8.03B2018-03-31: $1.71B2019-03-31: $1.83B2020-03-31: $3.41B2021-03-31: -$4.15B2022-03-31: $2.80B2023-03-31: $4.99B2024-03-31: $4.54B2025-03-31: $5.06B2026-03-31: $6.94B$6.94B
2009-03-31 EBITDA (USD) 2026-03-31
Period endedEBITDAChange YoYSource filing
2026-03-31$6.94B+37.2%2026-05-08, From 2025-04-01
2025-03-31$5.06B+11.3%2026-05-08, From 2024-04-01
2024-03-31$4.54B-8.9%2026-05-08, From 2023-04-01
2023-03-31$4.99B+78.3%2025-05-09, From 2022-04-01
2022-03-31$2.80Bn/m2024-05-08, From 2021-04-01
2021-03-31-$4.15Bn/m2023-05-09, From 2020-04-01
2020-03-31$3.41B+85.9%2022-05-09, From 2019-04-01
2019-03-31$1.83B+7.1%2021-05-12, From 2018-04-01
2018-03-31$1.71B-78.7%2020-05-22, From 2017-04-01
2017-03-31$8.03B+81.3%2019-05-15, From 2016-04-01
2016-03-31$4.43B+11.2%2018-05-24, From 2015-04-01
2015-03-31$3.98B+25.6%2017-05-22, From 2014-04-01
2014-03-31$3.17B+8.4%2016-05-05, From 2013-04-01
2013-03-31$2.93Bn/c2015-05-12, From 2012-04-01
2012-03-31$2.62Bn/c2014-05-14, From 2011-04-01
2011-03-31$2.32B-6.8%2013-05-07, From 2010-04-01
2010-03-31$2.48Bn/c2012-05-02, From 2009-04-01
2009-03-31$1.51Bn/a2011-05-05, From 2008-04-01

EBITDA at similar companies

Companies with the same SEC industry code (Wholesale-Drugs, Proprietaries & Druggists' Sundries), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedEBITDAChange YoY
McKesson Corp (MCK)2026-03-31$6.94B+37.2%
Cencora, Inc. (COR)2025-09-30$3.68B+12.6%
Cardinal Health Inc (CAH)2026-06-30$3.57B+16.4%
Herbalife Ltd. (HLF)2025-12-31$602.20M+18.7%
Nu Skin Enterprises, Inc. (NUS)2025-12-31$118.02Mn/m
Cosmos Health Inc. (COSM)2025-12-31-$15.33Mn/m
DataMeds AI, Inc. (MEDS)2025-12-31-$90.54Mn/m
Stemtech Corp (STEK)2025-12-31-$2.54Mn/m

Compare MCK, COR, CAH, HLF side by side · Screen every company in Wholesale-Drugs, Proprietaries & Druggists' Sundries ↗